Integrated Biopharma (OTC:INBP) Stock, Quote.Headers.trade-ideas

Integrated Biopharma Inc is a pharmaceutical company engaged in manufacturing, distributing, marketing, and selling vitamins, nutritional supplements, and herbal products. It operates in two segments; Contract Manufacturing and Other Nutraceutical Businesses. Key revenue is generated from Contract Manufacturing segment which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers.

News

Penny Stocks

Small Cap

Markets

General

ATLANTIC SAPPHIRE AS by Atlantic Sapphire AS

AASZF

AHCCF

BIG BLOCKCHAIN INTELGNCE by Big Blockchain Intelligence Group Inc.

BBKCF

BDRBF

BITW

BLSTF

BTVCY

CCHWF

CTUY

EDVMF

EQFN

GNRV

GRAMF

GTBIF

INBC

INBP

NCAUF

NDVAF

NXGWF

PRIME MERIDIAN HLDG CO by Prime Meridian Holding Co.

PMHG

RWBYF

TAOIF

TLLTF

TRNLY

TRSSF

VREOF

WDDMF

ZOEIF

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

Multiple Miners Make Their Way In for Q1 OTC Market Index Rebalancing

Intraday Update

Movers

Trading Ideas

ACAZF

ACLLF

ADGS

AFGC

AGNC

AKABY

AKBA

AMSWA

ARCE

ASAZY

ASND

AUCOY

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

BABYF

BAESF

BWMG

BXMT

BXRX

CELTF

CHCT

CLGN

CLNXF

CNNE

CSYJF

CTXXF

CUSI

CWST

DLT RESOLUTION INC by DLT Resolution Inc.

DLTI

DOOR

DYFSF

EHTH

EXXRF

FATE

FCPT

FLTCF

FPNUF

FRPT

FRTA

FSPKF

FTMNF

GLDLF

GLOB

GLPI

GOLD

GRBK

GRFS

GRIF

HALO

Hannon Armstrong Sustainable Infrastructure Capital

HASI

HLMAF

HTGC

IDXG

ILPT

INFN

ISVLF

Stocks That Hit 52-Week Highs On Friday

ABBRF

ACGL

ADBE

ADSK

ADVM

AEHR

AEMMY

AMRC

AMWD

AMXEF

ANSS

ARCAY

ARCVF

ARDC

ARNC

ASHTY

ATVI

AVXL

AZMTF

AZRE

BLDP

BLDR

BRSGF

BWXT

CACI

CALA

CCYC

CDNS

CELH

CEVA

CGEN

CHDN

CHTR

CLGX

CLPBY

COST

CRMT

CROL

CSLLY

CTAS

CVNA

CWEN

CWEN-A

DBOEY

DGIF

DNNGY

DOCU

DOGEF

DOOO

Stocks That Hit 52-Week Highs On Wednesday

INTEGRATED BIOPHARMA INC by Integrated BioPharma, Inc.

Integrated Biopharma Inc

Dina Masi, Chief Financial Officer at Integrated Biopharma (OTC:<a class="ticker" href="https://www.benzinga.com/stock/INBP#OTC">INBP</a>), reported a large exercise of company stock options on September 21, according to a new SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001016504/000134528123000004//Archives/edgar/data/1016504/000134528123000004/0001345281-23-000004-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that Masi, Chief Financial Officer at Integrated Biopharma, a company in the Consumer Staples sector, just exercised stock options worth 50,000 shares of INBP stock with an exercise price of $0.09.
Integrated Biopharma shares are trading down 0.0% at $0.28 at the time of this writing on Friday morning. Since the current price is $0.28, this makes Masi's 50,000 shares worth $14,025.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. 
In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Important Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001016504">Check Out The Full List Of Integrated Biopharma's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Chief Financial Officer at Integrated Biopharma Exercises Options Worth $14K

Dina Masi, Chief Financial Officer at Integrated Biopharma (OTC:<a class="ticker" href="https://www.benzinga.com/stock/INBP#OTC">INBP</a>), reported a large exercise of company stock options on September 21, according to a new SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001016504/000134528123000004//Archives/edgar/data/1016504/000134528123000004/0001345281-23-000004-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that Masi, Chief Financial Officer at Integrated Biopharma, a company in the Consumer Staples sector, just exercised stock options worth 50,000 shares of INBP stock with an exercise price of $0.09.
Integrated Biopharma shares are trading down 0.0% at $0.28 at the time of this writing on Thursday morning. Since the current price is $0.28, this makes Masi's 50,000 shares worth $14,025.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Important</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. 
In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Important Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001016504">Check Out The Full List Of Integrated Biopharma's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Integrated Biopharma Chief Financial Officer Acquires 50,000 Shares After Exercising Company Stock Options

William H Milmoe, Board Member at Integrated Biopharma (OTC:<a class="ticker" href="https://www.benzinga.com/stock/INBP#OTC">INBP</a>), reported a large acquisition of company stock options on July 20, according to a new SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001016504/000134528123000003//Archives/edgar/data/1016504/000134528123000003/0001345281-23-000003-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that Milmoe, Board Member at Integrated Biopharma, a company in the Consumer Staples sector, was just awarded stock options worth 50,000 shares of INBP. The options give Milmoe the right to buy the company's stock at $0.0 per share.
Integrated Biopharma shares are trading down 1.46% at $0.33 at the time of this writing on Friday morning. Since the current price is $0.33, this makes Milmoe's 50,000 shares worth $16,500.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. 
In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Transaction Codes To Focus On</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001016504">Check Out The Full List Of Integrated Biopharma's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Board Member at Integrated Biopharma Acquires Company Stock Options Worth 50,000 Shares

Damon DeSantis, Board Member at Integrated Biopharma (OTC:<a class="ticker" href="https://www.benzinga.com/stock/INBP#OTC">INBP</a>), reported a large acquisition of company stock options on July 19, according to a new SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001016504/000134528123000001//Archives/edgar/data/1016504/000134528123000001/0001345281-23-000001-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday showed that DeSantis, Board Member at Integrated Biopharma, a company in the Consumer Staples sector, was just awarded stock options worth 50,000 shares of INBP. The options give DeSantis the right to buy the company's stock at $0.0 per share.
Integrated Biopharma shares are trading up 0.03% at $0.33 at the time of this writing on Thursday morning. Since the current price is $0.33, this makes DeSantis's 50,000 shares worth $16,745.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Important</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Important Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001016504">Check Out The Full List Of Integrated Biopharma's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Eric J Friedman, Director at Integrated Biopharma (OTC:<a class="ticker" href="https://www.benzinga.com/stock/INBP#OTC">INBP</a>), reported a large acquisition of company stock options on July 19, according to a new SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001016504/000134528123000002//Archives/edgar/data/1016504/000134528123000002/0001345281-23-000002-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday showed that Friedman, Director at Integrated Biopharma, a company in the Consumer Staples sector, was just awarded stock options worth 50,000 shares of INBP. The options give Friedman the right to buy the company's stock at $0.0 per share.
Integrated Biopharma shares are trading up 0.03% at $0.33 at the time of this writing on Thursday morning. Since the current price is $0.33, this makes Friedman's 50,000 shares worth $16,745.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Transaction Codes To Focus On</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001016504">Check Out The Full List Of Integrated Biopharma's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Director at Integrated Biopharma Acquires Company Stock Options Worth 50,000 Shares

The following post was written and/or published as a collaboration between Benzinga&rsquo;s in-house sponsored content team and a financial partner of Benzinga.
The <a href="https://www.benzinga.com/markets/cannabis/19/02/13168160/6-indexes-that-can-help-you-track-the-otc-markets">indices that track trading on OTC Markets</a> saw several changes occur in Q1. Here is a deeper look at the companies that were added and removed in each of the market&rsquo;s major indices that were rebalanced for the quarter:
<a href="https://www.otcmarkets.com/index/.OTCQX">OTCXC Composite Index</a>
The OTCX Composite Index, which is the benchmark for tracking the overall performance of the most transparent domestic and international companies on OTC Markets, closed up 3.9% in the first quarter. There were 58 new companies added to the index, including AYR Wellness Inc. (OTCWX: AYWRF), Blackstone Minerals Ltd. (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/blstf#OTCQX">BLSTF</a>), Integrated BioPharma, Inc. (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/inbp#OTCQX">INBP</a>), Newcore Gold Ltd. (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/ncauf#OTCQX">NCAUF</a>), Tilt Holdings Inc. (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/tlltf#OTCQX">TLLTF</a>), The Trendlines Group Ltd. (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/trnly#OTCQX">TRNLY</a>), and Zoetic International PLC (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/zoeif#OTCQX">ZOEIF</a>).&nbsp;
Twenty-seven companies were removed from the index including Lexaria Bioscience Corp. (LEXX), which graduated to Nasdaq on January 12, 2021, and URBAN-GRO (UGRO), which graduated to Nasdaq on February 12, 2021. Midas Gold Corp. changed its name to Perpetua Resources Corp. (PPTA) and graduated to Nasdaq on February 18, 2021. Ferguson Plc (FERG) graduated to NYSE on 3/8/2021.
<a href="https://www.otcmarkets.com/index/.OTCQXBIL">OTCXC Billion+ Index</a>
The OTCQX Billion+ Index, which tracks the performance of the $1 billion-plus market cap OTCQX companies, was up 3.6% for the quarter. Nine companies were added to the index including Atlantic Sapphire ASA (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/aaszf#OTCQX">AASZF</a>), Bombardier Inc. (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/bdrbf#OTCQX">BDRBF</a>), Bitwise 10 Crypto Index Fund (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/bitw#OTCQX">BITW</a>) and TerrAscend Corp. (OTCXQ: TRSSF).
<a href="https://www.otcmarkets.com/index/.OTCQXDIV">OTCXC Dividend Index</a>
The OTCQX Dividend Index, which tracks the dividend-paying U.S. and international OTCQX companies, was up 3.6% in the quarter. Fourteen new companies were added to the index including Britvic plc (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/btvcy#OTCQX">BTVCY</a>), Endeavour Mining Corporation (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/edvmf#OTCQX">EDVMF</a>), Prime Meridian Holding Co. (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/pmhg#OTCQX">PMHG</a>) and TAG Oil Ltd. (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/taoif#OTCQX">TAOIF</a>). Fifteen companies were removed from the index.
<a href="https://www.otcmarkets.com/index/.OTCQXBK">OTXCX Banks Index</a>
The OTCQX Banks Index, which is made up of OTCQX community and regional banks, increased 15.9% in the first quarter. Twelve banks were added to the index in the quarter and four companies were removed. Some of those banks included Century Next Financial Corp (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/ctuy#OTCQX">CTUY</a>), Equitable Financial Corp. (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/eqfn#OTCQX">EQFN</a>), Grand River Commerce Inc. (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/gnrv#OTCQX">GNRV</a>) and InBankshares, Corp (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/inbc#OTCQX">INBC</a>).
<a href="https://www.otcmarkets.com/index/.OTCQXINT">OTCXC International Index</a>
The OTCQX International Index, a benchmark for international OTCQX companies, was up 3.0% for the quarter. Thirty-one new companies were added to the index including Apollo Healthcare Corp. (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/ahccf#OTCQX">AHCCF</a>) and BIGG Digital Assets Inc. (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/bbkcf#OTCQX">BBKCF</a>).
<a href="https://www.otcmarkets.com/index/.OTCQXCAN">OTCXC Canada Index</a>
The OTCQX Canada Index, which tracks Canadian OTCQX companies, was up 11.9% in the first quarter. Twenty-five companies were added to the index and eight companies were removed.
<a href="https://www.otcmarkets.com/index/.OTCQXUS">OTCXC U.S. Index</a>
OTCQX U.S. Index, a benchmark for U.S. OTCQX companies, was up 16.5% in the first quarter. Twenty-five companies were added to the index and 13 companies were removed.
<a href="https://www.otcmarkets.com/index/.OTCQXMJ">OTCQX Cannabis Index</a>
OTCQX Cannabis Index, a benchmark for cannabis companies, was up 26% in the first quarter. Eleven new companies joined the index. The 11 companies added were Columbia Care Inc (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/cchwf#OTCQX">CCHWF</a>), TPCO HLDG CORP (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/gramf#OTCQX">GRAMF</a>), Green Thumb Industries Inc (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/gtbif#OTCQX">GTBIF</a>), Indiva Ltd. (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/ndvaf#OTCQX">NDVAF</a>), Next Green Wave (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/nxgwf#OTCQX">NXGWF</a>), Red White &amp; Bloom Brands Inc (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/rwbyf#OTCQX">RWBYF</a>), Tilt Holdings Inc (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/tlltf#OTCQX">TLLTF</a>), TerrAscend Corp. (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/trssf#OTCQX">TRSSF</a>), Vireo Health International Inc (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/vreof#OTCQX">VREOF</a>), WeedMD Inc (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/wddmf#OTCQX">WDDMF</a>) and&nbsp; Zoetic International PLC (OTCQX: <a class="ticker" href="https://www.benzinga.com/stock/zoeif#OTCQX">ZOEIF</a>). Eight companies were removed.
The preceding post was written and/or published as a collaboration between Benzinga&rsquo;s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.

Comments

Integrated Biopharma

Integrated Biopharma (INBP) Forecast

Integrated Biopharma (OTC:INBP) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga